No Data
No Data
Kubota Pharmaceutical HD---1Q strengthens preparations for Kubota Glass sales expansion and product improvement/service creation
Kubota Pharmaceutical Holdings <4596> announced consolidated financial results (IFRS) for the 1st quarter (January to March 24) of the fiscal year ending 2024/12 on the 14th. Business revenue decreased 2.8% from the same period last year to 0.05 billion yen, operating loss was 337 million yen (loss of 445 million yen in the same period last year), loss before income tax was 343 million yen (loss of 444 million yen), and quarterly losses attributable to owners of parent companies were 343 million yen (loss of 444 million yen). Wearable myopia device in medical devices
Kubota: confirmation letter
Kubota: Quarterly Report - 135th Quarter (2024/01/01 - 2024/03/31)
Kubota Pharma 1Q Loss Y343.00M Vs Loss Y444.00M
Kubota Pharmaceutical Holdings Co. Ltd. (4596.TO) Japan 1st Quarter Ended March 31 GROUP 2024 2023 Revenue Y5.00 mln Y5.00 mln Ope
Convertible Stock List (Part 3) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <5302> Nippon Carbon 5460 5660 <5423> East Steel 1653 1780 <5541> Taihei Yokin 1285 1348 <5631> Nippon Steel 3943 3973 <5714> DOWA 5721 60
Nikkei Average Contribution Ranking (advance closing) - The Nikkei Average continued to rise slightly, boosted by about 72 yen for the 2 brands SoftBank G and KDDI
The number of gains and falls of the Nikkei Average constituent stocks as of closing 13 days ago was 2 stocks unchanged: 85 stocks with price increases and 138 stocks with price drops. The Nikkei Average continued to rise slightly. The front-end transaction was closed at 38243.59 yen (estimated turnover of 1.01 billion shares), which was 14.48 yen higher (+0.04%) compared to the previous business day. The US stock market was mixed on the 10th. The Dow average rose by $125.08 (+ 0.32%) to $39512.84, and the Nasdaq depreciated 5.39 points (-0.03%) to 163
No Data